Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Business Strategies & IT
Hosted Informatics: Bringing Cloud Computing Down to Earth with Bottom-line Benefits for Pharma
By Symyx Technologies. Hosted informatics brings high-value scientific information and applications to scientists’ desktops. A subscription-based, software-as-a-service (SaaS) model lets pharma organizations improve operational agility, collaborate more effectively with virtual teams and partners, focus on their core strengths, and lower costs.
Slim down with lean quality
During these turbulent economic times, everybody is talking about slimming down and becoming lean. The top 16 pharmaceutical manufacturers spent over $90 billion to manufacture drugs but half is considered wasted money and an estimated 95% of activities in any pharmaceutical plant fail to add value to the product.
Clinical Process Modeling – Taking Control Now
Ethan Smith of Metastorm explains a successful approach to the drug development process.
Big Pharma’s Changing Landscape: What Does Market Consolidation Mean for IT Service Delivery
By HP. In the wake of shrinking pipelines, rising research and development (R&D) costs, and the US Food and Drug Administration’s hyper conservative approach in drug approvals, a major trend toward consolidation has emerged.
Regulatory Gap Analysis to Assess Internal Cold Chain Compliance
By Alternatives Technologie Pharma Inc. Perform periodic Regulatory Gap Analysis to assess and maintain your Cold Chain Compliance (Storage, Handling and Distribution).
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.